Tailored Versus Empiric Therapy for Helicobacter Pylori Treatment
Status:
Completed
Trial end date:
2018-03-31
Target enrollment:
Participant gender:
Summary
With markedly increased antibiotic resistance and unsatisfactory efficacies of common empiric
eradication regimens in the mainland of China, tailored therapy may be the best choice to
achieve good efficacy. This study compared the eradication rates, safety, and compliance of
antibiotic sensitivity-based tailored therapy compared with empiric bismuth quadruple therapy
in the naive patients with Helicobacter pylori infection.